Document is current
Any future updates will be listed below
-
Authors
Campisi, Manuela https://orcid.org/0000-0002-7372-4136
Cannella, Luana https://orcid.org/0000-0002-3827-3632
Paccagnella, Omar
Brazzale, Alessandra R.
Agnolin, Alberto
Grothe, Torsten
Baumann, Julia
Pavanello, Sofia https://orcid.org/0000-0002-5229-9900
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 20 February 2025
First Online: 10 March 2025
Declarations
: The clinical trial was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the University of Padova (Approval No. 5518/AO/22; Study Code: EMODISU) on December 6, 2022. All participants provided written informed consent prior to enrollment.
: Consent for publication was obtained from each participant.
: J.B. and T.G. are Scientific Project Manager and Head of Food & Health, respectively, of Mibelle Group Biochemistry (Buchs, Switzerland), which formulated and manufactured the Monarda didyma L. extract-based supplement. The other authors report no conflicts of interest.
